Latest edition: 23 April 2025
Latest edition: 23 April 2025
The agreement gives Boehringer access to Tessellate鈥檚 novel approach targeting ALT-dependent tumours.
The EU-wide JCAs come with both advantages and disadvantages.
Regeneron is currently expanding its Tarrytown campus with an investment of nearly $3.6bn.
Translational360 is a recently introduced integrated research-grade longitudinal clinical molecular database.
The collaboration is scrutinising data from 30,000 subjects to pinpoint those at high risk.
The deal between the companies includes upfront and milestone payments, as well as royalties on future sales.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.
